Advertisement
Screener

TuHURA BIOSCIENCES, INC./NV (HURA) General and Administrative Expense

2.8 / 5 stars · 68/120 Roast Me

TuHURA BIOSCIENCES, INC./NV General and Administrative Expense

TuHURA BIOSCIENCES, INC./NV (HURA) reported General and Administrative Expense of $2.14 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.

Financial Statements › Expense Statement › Operating Expenses

us-gaap:GeneralAndAdministrativeExpense · last filed 2026-08-14

  • TuHURA BIOSCIENCES, INC./NV general and administrative expense for the quarter ending 2026-06-30 was $2.14M, a 15.09% increase year-over-year.
  • TuHURA BIOSCIENCES, INC./NV general and administrative expense for the quarter ending 2026-03-31 was $2.30M, a 13.94% increase year-over-year.
  • TuHURA BIOSCIENCES, INC./NV general and administrative expense for the quarter ending 2025-12-31 was -$1.56M, a 222.20% decline year-over-year.
  • TuHURA BIOSCIENCES, INC./NV general and administrative expense for the quarter ending 2025-09-30 was $1.76M, a 124.77% increase year-over-year.
  • TuHURA BIOSCIENCES, INC./NV general and administrative expense for fiscal 2025 was $7.58M, a 95.77% increase from fiscal 2024.
  • TuHURA BIOSCIENCES, INC./NV general and administrative expense for fiscal 2024 was $3.87M.
  • TuHURA BIOSCIENCES, INC./NV general and administrative expense for fiscal 2024 was $5.79M.
  • TuHURA BIOSCIENCES, INC./NV general and administrative expense for fiscal 2023 was $4.14M.
Period endGeneral and Administrative Expense 3 monthGeneral and Administrative Expense 3 month as first filedGeneral and Administrative Expense 6 monthGeneral and Administrative Expense 6 month as first filedGeneral and Administrative Expense 9 monthGeneral and Administrative Expense 9 month as first filedGeneral and Administrative Expense 12 monthGeneral and Administrative Expense 12 month as first filedGeneral and Administrative Expense 14 monthGeneral and Administrative Expense 36 monthGeneral and Administrative Expense 39 monthGeneral and Administrative Expense 42 monthGeneral and Administrative Expense 45 monthGeneral and Administrative Expense 48 month
2026-06-30$2.14M
10-Q · filed 2026-08-14
$4.44M
10-Q · filed 2026-08-14
$2.88M
derived: sum of 3 quarters · filed 2026-08-14
$4.64M
derived: sum of 4 quarters · filed 2026-08-14
2026-03-31$2.30M
10-Q · filed 2026-05-15
$735.63K
derived: sum of 2 quarters · filed 2026-05-15
$2.50M
derived: sum of 3 quarters · filed 2026-05-15
$4.36M
derived: sum of 4 quarters · filed 2026-08-14
2025-12-31-$1.56M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31
$199.28K
derived: sum of 2 quarters · filed 2026-03-31
$2.06M
derived: sum of 3 quarters · filed 2026-08-14
$7.58M
10-K · filed 2026-03-31
2025-09-30$1.76M
10-Q · filed 2025-11-14
$3.62M
derived: sum of 2 quarters · filed 2026-08-14
$9.15M
10-Q · filed 2025-11-14
$6.92M
derived: sum of 4 quarters · filed 2026-08-14
2025-06-30$1.86M
10-Q · filed 2026-08-14
$4.95M
10-Q · filed 2025-08-14
$3.88M
10-Q · filed 2026-08-14
$7.38M
10-Q · filed 2025-08-14
$5.16M
derived: sum of 3 quarters · filed 2026-08-14
$5.94M
derived: sum of 4 quarters · filed 2026-08-14
2025-03-31$2.02M
10-Q · filed 2026-05-15
$2.44M
10-Q · filed 2025-05-15
$3.29M
derived: sum of 2 quarters · filed 2026-05-15
$4.08M
derived: sum of 3 quarters · filed 2026-05-15
$4.87M
derived: sum of 4 quarters · filed 2026-05-15
2024-12-31$1.28M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31
$2.06M
derived: sum of 2 quarters · filed 2026-03-31
$2.86M
derived: sum of 3 quarters · filed 2026-03-31
$3.87M
10-K · filed 2026-03-31
$4.31M
10-K · filed 2025-03-31
2024-09-30$783.46K
10-Q · filed 2025-11-14
$1.96M
10-Q · filed 2024-11-14
$1.58M
derived: sum of 2 quarters · filed 2025-11-14
$2.60M
10-Q · filed 2025-11-14
$3.50M
derived: sum of 4 quarters · filed 2025-11-14
2024-06-30$795.66K
10-Q · filed 2025-08-14
$1.81M
10-Q · filed 2025-08-14
$2.72M
derived: sum of 3 quarters · filed 2025-08-14
$5.79M
10-K · filed 2024-10-07
2024-03-31$1.02M
10-Q · filed 2025-05-15
$1.49M
10-Q · filed 2024-05-14
$1.92M
derived: sum of 2 quarters · filed 2025-05-15
$3.50M
10-Q · filed 2024-05-14
$4.30M
derived: sum of 4 quarters · filed 2025-05-15
2023-12-31$908.00K
10-Q · filed 2024-02-14
$2.01M
10-Q · filed 2024-02-14
$3.28M
derived: sum of 3 quarters · filed 2024-11-14
$4.14M
10-K · filed 2025-03-31
2023-09-30$1.10M
10-Q · filed 2024-11-14
$2.38M
derived: sum of 2 quarters · filed 2024-11-14
$3.67M
derived: sum of 3 quarters · filed 2024-11-14
$5.11M
derived: sum of 4 quarters · filed 2024-11-14
2023-06-30$1.27M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-10-07
$2.57M
derived: sum of 2 quarters · filed 2024-10-07
$4.01M
derived: sum of 3 quarters · filed 2024-10-07
$5.49M
10-K · filed 2024-10-07
2023-03-31$1.30M
10-Q · filed 2024-05-14
$2.74M
derived: sum of 2 quarters · filed 2024-05-14
$4.21M
10-Q · filed 2024-05-14
$5.67M
derived: sum of 4 quarters · filed 2024-05-14
2022-12-31$1.44M
10-Q · filed 2024-02-14
$2.92M
10-Q · filed 2024-02-14
$4.37M
derived: sum of 3 quarters · filed 2024-02-14
$6.25M
derived: sum of 4 quarters · filed 2024-02-14
2022-09-30$1.48M
10-Q · filed 2023-11-13
$2.93M
derived: sum of 2 quarters · filed 2023-11-13
$4.81M
derived: sum of 3 quarters · filed 2023-11-13
$6.81M
derived: sum of 4 quarters · filed 2023-11-13
2022-06-30$1.45M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-09-18
$3.34M
derived: sum of 2 quarters · filed 2023-09-18
$5.33M
derived: sum of 3 quarters · filed 2023-09-18
$7.51M
10-K · filed 2023-09-18
2022-03-31$1.88M
10-Q · filed 2023-05-11
$3.88M
derived: sum of 2 quarters · filed 2023-05-11
$6.05M
10-Q · filed 2023-05-11
$8.72M
derived: sum of 4 quarters · filed 2023-05-11
2021-12-31$1.99M
10-Q · filed 2023-02-14
$4.17M
10-Q · filed 2023-02-14
$6.84M
derived: sum of 3 quarters · filed 2023-02-14
$9.60M
derived: sum of 4 quarters · filed 2023-02-14
2021-09-30$2.18M
10-Q · filed 2022-11-09
$4.84M
derived: sum of 2 quarters · filed 2022-11-09
$7.61M
derived: sum of 3 quarters · filed 2022-11-09
$10.40M
derived: sum of 4 quarters · filed 2022-11-09
2021-06-30$2.67M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-09-27
$5.43M
derived: sum of 2 quarters · filed 2022-09-27
$8.22M
derived: sum of 3 quarters · filed 2022-09-27
$9.76M
10-K · filed 2022-09-27
2021-03-31$2.76M
10-Q · filed 2022-05-13
$5.56M
derived: sum of 2 quarters · filed 2022-05-13
$7.09M
10-Q · filed 2022-05-13
$8.56M
derived: sum of 4 quarters · filed 2022-05-13
2020-12-31$2.79M
10-Q · filed 2022-02-11
$4.33M
10-Q · filed 2022-02-11
$5.80M
derived: sum of 3 quarters · filed 2022-02-11
$6.87M
derived: sum of 4 quarters · filed 2022-02-11
2020-09-30$1.53M
10-Q · filed 2021-11-15
$3.00M
derived: sum of 2 quarters · filed 2021-11-15
$4.08M
derived: sum of 3 quarters · filed 2021-11-15
$5.13M
derived: sum of 4 quarters · filed 2021-11-15
2020-06-30$1.47M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-09-28
$2.55M
derived: sum of 2 quarters · filed 2021-09-28
$3.60M
derived: sum of 3 quarters · filed 2021-09-28
$4.51M
10-K · filed 2021-09-28
$4.51M
10-K · filed 2020-09-18
2020-03-31$1.08M
10-Q · filed 2021-05-13
$1.08M
10-Q · filed 2020-05-13
$2.13M
derived: sum of 2 quarters · filed 2021-05-13
$3.04M
10-Q · filed 2021-05-13
$3.05M
10-Q · filed 2020-05-13
$4.98M
derived: sum of 4 quarters · filed 2021-05-13
2019-12-31$1.05M
10-Q · filed 2021-02-12
$1.05M
10-Q · filed 2020-02-13
$1.97M
10-Q · filed 2021-02-12
$1.97M
10-Q · filed 2020-02-13
$3.91M
derived: sum of 3 quarters · filed 2021-02-12
$4.84M
derived: sum of 4 quarters · filed 2021-02-12
2019-09-30$914.00K
10-Q · filed 2020-11-12
$913.63K
10-Q · filed 2019-11-13
$2.85M
derived: sum of 2 quarters · filed 2020-11-12
$3.79M
derived: sum of 3 quarters · filed 2020-11-12
$4.66M
derived: sum of 4 quarters · filed 2020-11-12
2019-06-30$1.94M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-09-18
$2.88M
derived: sum of 2 quarters · filed 2020-09-18
$3.75M
derived: sum of 3 quarters · filed 2020-09-18
$4.74M
10-K · filed 2020-09-18
-$4.74M
10-K · filed 2019-09-09
2019-03-31$935.53K
10-Q · filed 2020-05-13
$1.81M
derived: sum of 2 quarters · filed 2020-05-13
$2.80M
10-Q · filed 2020-05-13
-$4.16M
derived: sum of 4 quarters · filed 2020-05-13
2018-12-31$874.88K
10-Q · filed 2020-02-13
$1.86M
10-Q · filed 2020-02-13
-$5.09M
derived: sum of 3 quarters · filed 2020-02-13
-$3.94M
derived: sum of 4 quarters · filed 2020-02-13
2018-09-30$986.47K
10-Q · filed 2019-11-13
-$5.97M
derived: sum of 2 quarters · filed 2019-11-13
-$4.81M
derived: sum of 3 quarters · filed 2019-11-13
-$3.80M
derived: sum of 4 quarters · filed 2019-11-13
2018-06-30-$6.95M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-09-09
-$5.80M
derived: sum of 2 quarters · filed 2019-09-09
-$4.79M
derived: sum of 3 quarters · filed 2019-09-09
-$4.04M
10-K · filed 2019-09-09
2018-03-31$1.16M
10-Q · filed 2019-05-14
$2.17M
derived: sum of 2 quarters · filed 2019-05-14
$2.91M
10-Q · filed 2019-05-14
$3.64M
derived: sum of 4 quarters · filed 2019-06-03
2017-12-31$1.01M
10-Q · filed 2019-02-11
$1.76M
10-Q · filed 2019-02-11
$2.49M
derived: sum of 3 quarters · filed 2019-06-03
$3.19M
derived: sum of 4 quarters · filed 2019-06-03
2017-09-30$744.62K
10-Q · filed 2018-11-13
$1.48M
derived: sum of 2 quarters · filed 2019-06-03
$2.17M
derived: sum of 3 quarters · filed 2019-06-03
$2.75M
derived: sum of 4 quarters · filed 2019-06-03
2017-06-30$731.14K
derived: 8-K 12 month − 10-Q 9 month · filed 2019-06-03
$1.43M
derived: sum of 2 quarters · filed 2019-06-03
$2.00M
derived: sum of 3 quarters · filed 2019-06-03
$3.32M
8-K · filed 2019-06-03
2017-03-31$698.13K
10-Q · filed 2018-05-15
-$698.13K
10-Q · filed 2017-05-12
$1.27M
derived: sum of 2 quarters · filed 2018-05-15
$2.59M
10-Q · filed 2018-05-15
-$2.59M
10-Q · filed 2017-05-12
$7.43M
derived: sum of 4 quarters · filed 2018-05-15
2016-12-31$571.29K
10-Q · filed 2018-02-14
$1.89M
10-Q · filed 2018-02-14
$6.74M
derived: sum of 3 quarters · filed 2018-02-14
$6.11M
derived: sum of 4 quarters · filed 2018-02-14
2016-09-30$1.32M
10-Q · filed 2017-11-09
$6.16M
derived: sum of 2 quarters · filed 2017-11-09
$5.53M
derived: sum of 3 quarters · filed 2017-11-09
$6.43M
derived: sum of 4 quarters · filed 2017-11-09
2016-06-30$4.85M
derived: 10-K 12 month − 10-Q 9 month · filed 2017-09-27
$4.22M
derived: sum of 2 quarters · filed 2017-09-27
$5.11M
derived: sum of 3 quarters · filed 2017-09-27
$2.85M
10-K · filed 2017-09-27
2016-03-31-$630.23K
10-Q · filed 2017-05-12
$630.23K
10-Q · filed 2016-05-12
$260.45K
derived: sum of 2 quarters · filed 2017-05-12
-$1.99M
10-Q · filed 2017-05-12
$1.99M
10-Q · filed 2016-05-12
$1.30M
derived: sum of 4 quarters · filed 2017-05-12
2015-12-31$890.67K
10-Q · filed 2017-02-10
$1.36M
10-Q · filed 2017-02-10
$1.93M
derived: sum of 3 quarters · filed 2017-02-10
$2.43M
derived: sum of 4 quarters · filed 2017-02-10
2015-09-30$474.02K
10-Q · filed 2016-11-10
-$474.02K
10-Q · filed 2015-11-16
$1.04M
derived: sum of 2 quarters · filed 2016-11-10
$1.54M
derived: sum of 3 quarters · filed 2016-11-10
$2.20M
derived: sum of 4 quarters · filed 2016-11-10
2015-06-30$566.92K
derived: 10-K 12 month − 10-Q 9 month · filed 2016-09-13
$1.07M
derived: sum of 2 quarters · filed 2016-09-13
$1.72M
derived: sum of 3 quarters · filed 2016-09-13
$2.17M
10-K · filed 2016-09-13
-$2.17M
10-K · filed 2015-09-03
2015-03-31$500.75K
10-Q · filed 2016-05-12
-$500.75K
10-Q · filed 2015-05-15
$1.16M
derived: sum of 2 quarters · filed 2016-05-12
$1.60M
10-Q · filed 2016-05-12
-$1.60M
10-Q · filed 2015-05-15
$3.44M
derived: sum of 4 quarters · filed 2016-05-12
2014-12-31$656.23K
10-Q · filed 2016-02-12
-$656.23K
10-Q · filed 2015-02-12
$1.10M
10-Q · filed 2016-02-12
-$1.10M
10-Q · filed 2015-02-12
$2.94M
derived: sum of 3 quarters · filed 2016-02-12
$1.97M
derived: sum of 4 quarters · filed 2016-02-12
2014-09-30-$445.00K
10-Q · filed 2015-11-16
$2.28M
derived: sum of 2 quarters · filed 2015-11-16
$1.31M
derived: sum of 3 quarters · filed 2015-11-16
$675.68K
derived: sum of 4 quarters · filed 2015-11-16
2014-06-30$2.72M
derived: 10-K 6 month − 10-Q 3 month · filed 2014-08-28
$1.76M
10-K · filed 2014-08-28
$1.12M
derived: sum of 3 quarters · filed 2015-05-15
-$3.13M
10-K · filed 2015-11-16
2014-03-31-$966.92K
10-Q · filed 2015-05-15
$966.92K
10-Q · filed 2014-05-15
-$1.60M
derived: sum of 2 quarters · filed 2015-05-15
-$2.34M
10-Q · filed 2015-05-15
-$690.09K
derived: sum of 4 quarters · filed 2015-05-15
$6.38M
10-Q · filed 2014-05-15
2013-12-31-$636.18K
10-Q · filed 2015-02-12
-$1.38M
10-Q · filed 2015-02-12
$276.83K
derived: sum of 3 quarters · filed 2015-02-12
$3.95M
10-K · filed 2014-08-28
$5.42M
10-K · filed 2014-03-10
2013-09-30-$741.37K
10-Q · filed 2014-11-07
$741.37K
10-Q · filed 2013-11-08
$913.01K
derived: sum of 2 quarters · filed 2014-11-07
$3.32M
10-Q · filed 2013-11-08
$2.21M
derived: sum of 4 quarters · filed 2014-11-07
$4.78M
10-Q · filed 2013-11-08
2013-06-30$1.65M
10-Q · filed 2013-08-12
$2.57M
10-K · filed 2014-08-28
$2.95M
derived: sum of 3 quarters · filed 2014-08-28
$3.17M
derived: sum of 4 quarters · filed 2014-08-28
$4.04M
10-Q · filed 2013-08-12
2013-03-31$920.38K
10-Q · filed 2014-05-15
$1.29M
derived: sum of 2 quarters · filed 2014-08-28
$1.51M
derived: sum of 3 quarters · filed 2014-08-28
$1.91M
derived: sum of 4 quarters · filed 2014-08-28
$2.38M
10-Q · filed 2013-05-15
2012-12-31$373.28K
derived: 10-K 12 month − 10-Q 9 month · filed 2014-08-28
$592.01K
derived: sum of 2 quarters · filed 2014-08-28
$986.80K
derived: sum of 3 quarters · filed 2014-08-28
$1.15M
10-K · filed 2014-08-28
2012-09-30$218.73K
10-Q · filed 2013-11-08
$4.16K
10-Q/A · filed 2012-12-20
$613.52K
derived: sum of 2 quarters · filed 2013-11-08
$781.32K
10-Q · filed 2013-11-08
$61.76K
10-Q/A · filed 2012-12-20
2012-06-30$394.79K
10-Q · filed 2013-08-12
$562.58K
10-Q · filed 2013-08-12
2012-03-31$167.79K
10-Q · filed 2013-05-15
2011-12-31$241.80K
10-K · filed 2014-03-10
2011-09-30$3.86K
10-Q/A · filed 2012-12-20

Similar stocks

Stock NameCountryMarket CapPE Ratio
Unicycive Therapeutics, Inc. (UNCY)United States$0.134B-3.70
Curanex Pharmaceuticals Inc (CURX)United States$0.138B
NRX Pharmaceuticals, Inc. (NRXP)United States$0.131B-6.31
MEDICINOVA INC (MNOV)United States$0.130B-6.04
Atrium Therapeutics, Inc. (RNA)United States$0.140B
Korro Bio, Inc. (KRRO)United States$0.141B-1.81
SPRUCE BIOSCIENCES, INC. (SPRB)United States$0.142B-2.89
IMMUNIC, INC. (IMUX)United States$0.127B-1.88
INOVIO PHARMACEUTICALS, INC. (INO)United States$0.125B-1.35
Corbus Pharmaceuticals Holdings, Inc. (CRBP)United States$0.144B-1.72